Irene Rivero‐Calle

Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

Sonia Ares‐Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez et al. · The Lancet Infectious Diseases · 2024 · 237 citations

Medicine, Infectious Diseases, Pediatrics +10

Adeno-associated virus 2 infection in children with non-A–E hepatitis

Antonia Ho, Richard Orton, Rachel Tayler et al. · Nature · 2023 · 171 citations · Full text

Medicine, Immunology, Infectious Diseases +17

Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS)

Navin P. Boeddha, Luregn J. Schlapbach, Gertjan J. Driessen et al. · Critical Care · 2018 · 158 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +16

Genomic investigations of unexplained acute hepatitis in children

Sofia Morfopoulou, Sarah Buddle, Oscar Enrique Torres Montaguth et al. · Nature · 2023 · 130 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

Deidre Wilkins, Annefleur C Langedijk, Robert Jan Lebbink et al. · The Lancet Infectious Diseases · 2023 · 105 citations

Life Sciences, Infectious Diseases, Molecular Biology +14